Prehosptial low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial

Comment

Frank X Guyette et al. J Trauma Acute Care Surg. 2022.

. 2022 Nov 1;93(5):e175-e176.

doi: 10.1097/TA.0000000000003686. Epub 2022 Jun 14.

No abstract available

Comment on

Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial.
Guyette FX, Zenati M, Triulzi DJ, Yazer MH, Skroczky H, Early BJ, Adams PW, Brown JB, Alarcon L, Neal MD, Forsythe RM, Zuckerbraun BS, Peitzman AB, Billiar TR, Sperry JL. Guyette FX, et al. J Trauma Acute Care Surg. 2022 May 1;92(5):839-847. doi: 10.1097/TA.0000000000003551. Epub 2022 Jan 25. J Trauma Acute Care Surg. 2022. PMID: 35081595 Free PMC article. Clinical Trial.
Prehospital low titer group O whole blood: Difficult to conclude?
Cazes N, Corcostegui SP, Boutillier du Retail C. Cazes N, et al. J Trauma Acute Care Surg. 2022 Nov 1;93(5):e175. doi: 10.1097/TA.0000000000003637. Epub 2022 Jun 14. J Trauma Acute Care Surg. 2022. PMID: 35696354 No abstract available.

1. Guyette FX, Zenati M, Triulzi DJ, Yazer MH, Skroczky H, Early BJ, et al. Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial. J Trauma Acute Care Surg . 2022;92(5):839–847.
1. Guyette FX, Brown JB, Zenati MS, Early-Young BJ, Adams PW, Eastridge BJ, et al.; STAAMP Study Group. Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial. JAMA Surg . 2020;156(1):11–20.
1. Li SR, Guyette F, Brown J, Zenati M, Reitz KM, Eastridge B, et al. Early prehospital tranexamic acid following injury is associated with a 30-day survival benefit: a secondary analysis of a randomized clinical trial. Ann Surg . 2021;274(3):419–426.